The country confirmed 63,430 new cases, taking the nationwide count to 7,873,830, it added.
Brazil is currently seeing a second wave of COVID-19 outbreaks, with a significant increase in cases since December that has pushed the public healthcare system to the brink of collapse in several regions.
Bangladeshi pharmaceutical company Globe Biotech has gotten approval from the Directorate General of Drug Administration (DGDA) for manufacturing Covid-19 vaccine for clinical trial on December 28.
Dr Mohammad Mohiuddin, Manager of Globe Biotech Limited (Head of Quality Operation), said “Vaccine will be available by June if we can begin the clinical trial this month,”
On October 5, the Bangladeshi pharmaceutical company said they have completed all the necessary preparations for making their vaccine initiative a success, but they said everything depended on the government’s cooperation in completing the required processes.
Meanwhile, Bangladesh is also set to purchase Oxford–AstraZeneca vaccine from the Serum Institute of India Pvt Ltd.
On Sunday, India, the world’s second-most populous country, authorised its first two COVID-19 vaccines — the Oxford-AstraZeneca one and another developed by an Indian company.
In Bangladesh, Foreign Minister Dr AK Abdul Momen on Monday cleared confusion about the timely delivery of Covid-19 vaccine to Bangladesh, saying it will get the vaccine from India on time.
"A decision has been taken at the highest level and that would be implemented. Nobody has to worry or get panicked," he told reporters sharing the updates they received from the Indian Ministry of External Affairs.
Health Minister Zahid Maleque also assured that Bangladesh will receive the Oxford-AstraZeneca Covid-19 vaccine from the Serum Institute on time.